Clinical Trial Update: Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing the safety and immunologic effects of low-dose versus high-dose vitamin D3 in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Multiple Sclerosis, Vitamin D Deficiency | Phase 1 | Status: COMPLETED